Cargando…

Elevated expression of CDK4 in lung cancer

BACKGROUND: The aim of the present study was to analyze the expression of Cyclin-dependent kinase 4 (CDK4) in lung cancer and its correlation with clinicopathologic features. Furthermore, the involvement of CDK4-mediated cell cycle progression and its molecular basis were investigated in the pathoge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Aibing, Wu, Bin, Guo, Jinsong, Luo, Weiren, Wu, Dong, Yang, Huiling, Zhen, Yan, Yu, Xiaoli, Wang, Hao, Zhou, Ying, Liu, Zhen, Fang, Weiyi, Yang, Zhixiong
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094221/ https://www.ncbi.nlm.nih.gov/pubmed/21477379 http://dx.doi.org/10.1186/1479-5876-9-38

Ejemplares similares

Knocking down CDK4 mediates the elevation of let-7c suppressing cell growth in nasopharyngeal carcinoma
por: Liu, Zhen, et al.
Publicado: (2014)

Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma
por: Liu, Zhen, et al.
Publicado: (2010)

ZEB2 Mediates Multiple Pathways Regulating Cell Proliferation, Migration, Invasion, and Apoptosis in Glioma
por: Qi, Songtao, et al.
Publicado: (2012)

Potential Tumor Suppressor NESG1 as an Unfavorable Prognosis Factor in Nasopharyngeal Carcinoma
por: Liu, Zhen, et al.
Publicado: (2011)

Reduced PDCD4 Expression Promotes Cell Growth Through PI3K/Akt Signaling in Non-Small Cell Lung Cancer
por: Zhen, Yan, et al.
Publicado: (2016)

CDK4/6 inhibitors: a novel strategy for tumor radiosensitization
por: Yang, Yilan, et al.
Publicado: (2020)

Candidate tumour suppressor CCDC19 regulates miR-184 direct targeting of C-Myc thereby suppressing cell growth in non-small cell lung cancers
por: Liu, Zhen, et al.
Publicado: (2014)

Meta-analysis on the association between pathologic complete response and triple-negative breast cancer after neoadjuvant chemotherapy
por: Wu, Kunpeng, et al.
Publicado: (2014)

Activation of the Hedgehog pathway mediates resistance to epidermal growth factor receptor inhibitors in non-small cell lung cancer
por: Chen, Hualin, et al.
Publicado: (2022)

CDK4 and miR-15a comprise an abnormal automodulatory feedback loop stimulating the pathogenesis and inducing chemotherapy resistance in nasopharyngeal carcinoma
por: Liu, Zhen, et al.
Publicado: (2016)

Retraction Note: CDK4 and miR-15a comprise an abnormal automodulatory feedback loop stimulating the pathogenesis and inducing chemotherapy resistance in nasopharyngeal carcinoma
por: Liu, Zhen, et al.
Publicado: (2021)

CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy
por: Bai, Xue, et al.
Publicado: (2023)

Concurrent versus sequential whole brain radiotherapy and TKI in EGFR-mutated NSCLC patients with brain metastasis: A single institution retrospective analysis
por: Chen, Hualin, et al.
Publicado: (2018)

NAP1L1 promotes proliferation and chemoresistance in glioma by inducing CCND1/CDK4/CDK6 expression through its interaction with HDGF and activation of c-Jun
por: Chen, Zigui, et al.
Publicado: (2021)

Abnormal Expression of Matrix Metalloproteinase-9 (MMP9) Correlates with Clinical Course in Chinese Patients with Endometrial Cancer
por: Yu, Fang, et al.
Publicado: (2012)

Beta-blocker and survival in patients with lung cancer: A meta-analysis
por: Lei, Zhen, et al.
Publicado: (2021)

Effects of an Indolocarbazole-Derived CDK4 Inhibitor on Breast Cancer Cells
por: Sun, Yuan, et al.
Publicado: (2011)

Reduced CTGF Expression Promotes Cell Growth, Migration, and Invasion in Nasopharyngeal Carcinoma
por: Zhen, Yan, et al.
Publicado: (2013)

Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma
por: Zhen, Yan, et al.
Publicado: (2013)

CDK14 expression is elevated in patients with non-small cell lung cancer and correlated with poor prognosis
por: Yang, Yong, et al.
Publicado: (2021)

PAQR4 promotes cell proliferation and metastasis through the CDK4-pRB-E2F1 pathway in non-small-cell lung cancer
por: Wu, Bin, et al.
Publicado: (2019)

Current Therapeutic Progress of CDK4/6 Inhibitors in Breast Cancer
por: Wu, Yanmei, et al.
Publicado: (2020)

δEF1 upregulates CDK4 transcription via the E2-box element on the CDK4 promoter
por: HU, FEN, et al.
Publicado: (2014)

Post-translational modifications of CDK5 and their biological roles in cancer
por: Gao, Gui-Bin, et al.
Publicado: (2021)

Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma
por: Tu, Luxia, et al.
Publicado: (2010)

The interplay of CDK4 and CDK6 in melanoma
por: Kollmann, Karoline, et al.
Publicado: (2019)

Abnormal spindle-like microcephaly-associated protein (ASPM) contributes to the progression of Lung Squamous Cell Carcinoma (LSCC) by regulating CDK4
por: Yuan, Ya-Jing, et al.
Publicado: (2020)

A directly negative interaction of miR-203 and ZEB2 modulates tumor stemness and chemotherapy resistance in nasopharyngeal carcinoma
por: Jiang, Qingping, et al.
Publicado: (2016)

CDK-mediated RNF4 phosphorylation regulates homologous recombination in S-phase
por: Luo, Kuntian, et al.
Publicado: (2015)

Gilteritinib Enhances Anti-Tumor Efficacy of CDK4/6 Inhibitor, Abemaciclib in Lung Cancer Cells
por: Sun, Chao-Yue, et al.
Publicado: (2022)

Abnormal spindle-like microcephaly-associated protein (ASPM) contributes to the progression of Lung Squamous Cell Carcinoma (LSCC) by regulating CDK4: Erratum
por: Yuan, Ya-Jing, et al.
Publicado: (2023)

Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma
por: Wu, Aibing, et al.
Publicado: (2015)

Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders
por: Wu, Xuewei, et al.
Publicado: (2021)

Phosphorylation of VP1 Mediated by CDK1-Cyclin B1 Facilitates Infectious Bursal Disease Virus Replication
por: Hu, Xifeng, et al.
Publicado: (2023)

Inducible deletion of CDK4 and CDK6 – deciphering CDK4/6 inhibitor effects in the hematopoietic system
por: Maurer, Barbara, et al.
Publicado: (2020)

Human sulfatase 1 exerts anti-tumor activity by inhibiting the AKT/ CDK4 signaling pathway in melanoma
por: Lou, Xiaoli, et al.
Publicado: (2016)

The RNA-binding protein LRPPRC promotes resistance to CDK4/6 inhibition in lung cancer
por: Zhou, Wei, et al.
Publicado: (2023)

Mechanisms of CDK4/6 Inhibitor Resistance in Luminal Breast Cancer
por: Li, Zhen, et al.
Publicado: (2020)

Regulation of CDK4
por: Bockstaele, Laurence, et al.
Publicado: (2006)

Differences in the Conformational Energy Landscape of CDK1 and CDK2 Suggest a Mechanism for Achieving Selective CDK Inhibition
por: Wood, Daniel J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nla0a14td6481j0ok3qtenkueo